Filing metadata

Accession number
0000902664-22-004363
Form type
Form 4
Filer
Landos Biopharma, Inc.
CIK
CIK 1785345
Filed
Sep 27, 2022
Reporting period
Sep 23, 2022
Description
Insider transaction

Explore SEC Filings Hub